3 results
Primary: To determine whether treatment with BKM120 plus fulvestrant prolongs PFS based on local investigator assessment compared to treatment with placebo plus fulvestrant for all patients regardless of PI3K pathway activation status (unkown status…
Primary objective: To evaluate the efficacy of inebilizumab in reducing the risk of a disease flare in patients with IgG4-RD.Secondary objectives:• To evaluate the safety and tolerability of inebilizumab in patients with IgG4-RD.• To evaluate the…
NMOSD is associated with a high degree of disability and mortality, and there is a unmet medical need in children with this disease.Results from the pivotal study (Study CD-IA-MEDI-551-1155) in adult patients with NMOSD demonstrated a 77% reduction…